(Q84315555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

review article

1 reference

title

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome

1 May 2020

main subject

0 references

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Wen Siang Tan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

author name string

Chean Yeah Yong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Swee Keong Yeap

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Kok Lian Ho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

2 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Microbiology

1 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

1781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 May 2020

copyright license

start time

2 August 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

12 December 2020

DNA and RNA-based vaccines: principles, progress and prospects

1 reference

12 December 2020

Vaccines and medicines for the world's poorest. Public-private partnerships seem to be essential

1 reference

12 December 2020

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

1 reference

12 December 2020

Nonhuman primates: a critical role in current disease research

1 reference

12 December 2020

Plasmid DNA vaccines: assay for integration into host genomic DNA

1 reference

12 December 2020

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

1 reference

12 December 2020

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

12 December 2020

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

12 December 2020

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

12 December 2020

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

1 reference

12 December 2020

Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.

1 reference

12 December 2020

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

1 reference

12 December 2020

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine

1 reference

12 December 2020

Induction of heterosubtypic immunity to influenza virus by intranasal immunization

1 reference

12 December 2020

Use of animal models in the development of human vaccines

1 reference

12 December 2020

Memory CD4 T cells: generation, reactivation and re-assignment

1 reference

12 December 2020

Rationalizing the development of live attenuated virus vaccines

1 reference

12 December 2020

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study

1 reference

12 December 2020

Clinical applications of DNA vaccines: current progress

1 reference

12 December 2020

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement

1 reference

12 December 2020

An animal model that reflects human disease: the common marmoset (Callithrix jacchus).

1 reference

12 December 2020

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

12 December 2020

Pneumonia from human coronavirus in a macaque model

1 reference

12 December 2020

Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

1 reference

12 December 2020

Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate

1 reference

12 December 2020

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

1 reference

12 December 2020

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses

1 reference

12 December 2020

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

1 reference

12 December 2020

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

1 reference

12 December 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

12 December 2020

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.

1 reference

12 December 2020

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

1 reference

12 December 2020

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

1 reference

12 December 2020

T cell-mediated immune response to respiratory coronaviruses

1 reference

12 December 2020

MERS coronaviruses in dromedary camels, Egypt.

1 reference

12 December 2020

Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013.

1 reference

12 December 2020

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

1 reference

12 December 2020

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

1 reference

12 December 2020

Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design

1 reference

12 December 2020

Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.

1 reference

12 December 2020

Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus

1 reference

12 December 2020

Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels

1 reference

12 December 2020

Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.

1 reference

12 December 2020

Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection.

1 reference

12 December 2020

Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease

1 reference

12 December 2020

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.

1 reference

12 December 2020

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits

1 reference

12 December 2020

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus

1 reference

12 December 2020

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.

1 reference

12 December 2020

Large animal models for vaccine development and testing.

1 reference

12 December 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

12 December 2020

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

1 reference

12 December 2020

Animal models of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

1 reference

12 December 2020

Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

1 reference

12 December 2020

Evaluation of candidate vaccine approaches for MERS-CoV.

1 reference

12 December 2020

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

1 reference

12 December 2020

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study

1 reference

12 December 2020

Developments in Viral Vector-Based Vaccines

1 reference

12 December 2020

Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis

1 reference

12 December 2020

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

1 reference

12 December 2020

Middle East respiratory syndrome: current status and future prospects for vaccine development

1 reference

12 December 2020

Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge

1 reference

12 December 2020

Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.

1 reference

12 December 2020

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

12 December 2020

An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity

1 reference

12 December 2020

Vaccines for the prevention against the threat of MERS-CoV.

1 reference

12 December 2020

MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques

1 reference

12 December 2020

Middle East respiratory syndrome vaccines

1 reference

12 December 2020

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

1 reference

12 December 2020

Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

1 reference

12 December 2020

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Unraveling the drivers of MERS-CoV transmission

1 reference

12 December 2020

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2.

1 reference

12 December 2020

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

1 reference

12 December 2020

Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants

1 reference

12 December 2020

One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus

1 reference

12 December 2020

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines

1 reference

12 December 2020

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

1 reference

12 December 2020

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

1 reference

12 December 2020

Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus

1 reference

12 December 2020

MERS-CoV spike protein: a key target for antivirals

1 reference

12 December 2020

Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice

1 reference

12 December 2020

Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

1 reference

12 December 2020

Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

1 reference

12 December 2020

DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice

1 reference

12 December 2020

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein

1 reference

12 December 2020

Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets.

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches.

1 reference

12 December 2020

Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.

1 reference

12 December 2020

Analysis of the genome sequence and prediction of B-cell epitopes of the envelope protein of Middle East respiratory syndrome-coronavirus

1 reference

12 December 2020

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

1 reference

12 December 2020

Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses.

1 reference

12 December 2020

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

1 reference

12 December 2020

Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance

1 reference

12 December 2020

Origins and pathogenesis of Middle East respiratory syndrome-associated coronavirus: recent advances

1 reference

12 December 2020

Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis

1 reference

12 December 2020

Virus like particles as a platform for cancer vaccine development.

1 reference

12 December 2020

A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization

1 reference

12 December 2020

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

1 reference

12 December 2020

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques.

1 reference

12 December 2020

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.

1 reference

12 December 2020

Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea.

1 reference

12 December 2020

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.

1 reference

12 December 2020

Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.

1 reference

12 December 2020

Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.

1 reference

12 December 2020

Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model

1 reference

12 December 2020

Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors

1 reference

12 December 2020

A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV

1 reference

12 December 2020

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

1 reference

12 December 2020

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

1 reference

12 December 2020

Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism

1 reference

12 December 2020

Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset

1 reference

12 December 2020

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

1 reference

12 December 2020

Choosing the right animal model for infectious disease research

1 reference

12 December 2020

A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model

1 reference

12 December 2020

Identifiers

DOI

10.3389/FMICB.2019.01781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31428074%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference